Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.19
-0.16 (-2.18%)
At close: Nov 7, 2025, 4:00 PM EST
7.35
+0.16 (2.23%)
After-hours: Nov 7, 2025, 7:15 PM EST
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $424.76 million as of November 7, 2025. Its market cap has decreased by -53.07% in one year.
Market Cap
424.76M
Enterprise Value
93.35M
1-Year Change
-53.07%
Ranking
Category
Stock Price
$7.19
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $424.76M, a decrease of -48.79%. That is a compound annual growth rate of -12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 424.76M | -40.11% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |